FDA Import Refusal AEK-8228133-6/11/1 — LABORATORIOS ASOFARMA
The FDA refused shipment AEK-8228133-6/11/1 from LABORATORIOS ASOFARMA (Mexico) on Feb 7, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75
Refusal Details
- Date
- Feb 7, 2025
- Country
- Mexico
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75